Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/13/2023 | Stoke Therapeutics, Inc. | STOK | Grant | Director Stock Option (Right to Buy) | 19.4k | $12.46 | $242.2k | | 06/13/2023 |
06/01/2023 | EXELIXIS, INC. | EXEL | Grant | Option (right to buy) | 44.1k | $19.39 | $854.8k | | 06/01/2023 |
06/07/2022 | Stoke Therapeutics, Inc. | STOK | Grant | Director Stock Option (Right to Buy) | 21k | $12.96 | $272.2k | | 06/07/2022 |
05/26/2022 | EXELIXIS, INC. | EXEL | Grant | Option (right to buy) | 42.4k | $18.19 | $771.7k | | 05/26/2022 |
06/08/2021 | Stoke Therapeutics, Inc. | STOK | Grant | Director Stock Option (Right to Buy) | 11.6k | $40.37 | $470.3k | | 06/08/2021 |
05/27/2021 | EXELIXIS, INC. | EXEL | Grant | | 16.4k | $0.00 | $0 | | 05/27/2021 |
06/03/2020 | Stoke Therapeutics, Inc. | STOK | Grant | Director Stock Option (Right to Buy) | 29.6k | $26.53 | $784.1k | | 06/03/2020 |
05/21/2020 | EXELIXIS, INC. | EXEL | Grant | | 15.5k | $0.00 | $0 | | 05/21/2020 |
01/15/2020 | Audentes Therapeutics, Inc. | BOLD | Disposition | Stock Option (Right to Buy) | 18k | $17.85 | $321.3k | | 01/15/2020 |
01/15/2020 | Audentes Therapeutics, Inc. | BOLD | Disposition | Stock Option (Right to Buy) | 9k | $0.00 | $0 | | 01/15/2020 |
01/15/2020 | Audentes Therapeutics, Inc. | BOLD | Disposition | Stock Option (Right to Buy) | 10k | $38.65 | $386.5k | | 01/15/2020 |
01/15/2020 | Audentes Therapeutics, Inc. | BOLD | Disposition | Stock Option (Right to Buy) | 16.2k | $24.74 | $400.8k | | 01/15/2020 |
05/23/2019 | EXELIXIS, INC. | EXEL | Grant | Option (right to buy) | 42.6k | $19.77 | $843k | | 05/23/2019 |
02/06/2019 | Audentes Therapeutics, Inc. | BOLD | Grant | Stock Option (right to buy) | 16.2k | $24.74 | $400.8k | | 02/06/2019 |
06/08/2018 | Audentes Therapeutics, Inc. | BOLD | Grant | Stock Option (right to buy) | 10k | $38.65 | $386.5k | | 06/08/2018 |
05/24/2018 | EXELIXIS, INC. | EXEL | Grant | Option (right to buy) | 31.2k | $20.50 | $638.9k | | 05/24/2018 |
10/08/2017 | Audentes Therapeutics, Inc. | BOLD | Grant | Stock Option (right to buy) | 9k | $26.01 | $234.1k | | 10/08/2017 |
01/01/2017 | Audentes Therapeutics, Inc. | BOLD | Grant | Stock Option (right to buy) | 18k | $17.85 | $321.3k | | 01/01/2017 |
10/25/2016 | HORIZON PHARMACEUTICAL LLC | RPTP | Disposition | Common Stock | 64.2k | $9.00 | $577.6k | | 10/24/2016 |
10/25/2016 | HORIZON PHARMACEUTICAL LLC | RPTP | Disposition | Stock Option(right to buy) | 152k | $5.27 | $801.3k | | 10/24/2016 |
10/25/2016 | HORIZON PHARMACEUTICAL LLC | RPTP | Disposition | Stock Option(right to buy) | 175k | $8.13 | $1.4M | | 10/24/2016 |
10/25/2016 | HORIZON PHARMACEUTICAL LLC | RPTP | Disposition | Stock Option(right to buy) | 240.6k | $3.74 | $899.8k | | 10/24/2016 |
10/24/2016 | HORIZON PHARMACEUTICAL LLC | RPTP | Other | Common Stock | 45.8k | $9.00 | $411.8k | | 10/24/2016 |
02/09/2016 | HORIZON PHARMACEUTICAL LLC | RPTP | Grant | | 64.2k | $0.00 | $0 | | 02/09/2016 |
02/09/2016 | HORIZON PHARMACEUTICAL LLC | RPTP | Grant | Stock options (right to buy) | 240.6k | $3.74 | $899.8k | | 02/09/2016 |